Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 2761061!ä!2761061 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       JAMA 1989 ; 262 (9): 1210-3 Nephropedia Template TP {{tp|p=2761061|t=1989. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department |pdf=|usr=}}{{2761061}} gab.com Text Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department JO: JAMA http://www.kidney.de/pget.php?&tw=1&pmid=2761061 #FOAvip Conventional nebulized beta-agonist therapy has met with disappointing results in an increasing number of moderate to severe asthmatics who may be characterized as "poor responders." Thirty-eight patients suffering from acute exacerbations of moderate to severe asthma were treated in an emergency department with an intravenous infusion of saline placebo or 1.2 g of magnesium sulfate after conventional beta-agonist therapy failed to produce significant improvement in peak expiratory flow rate. Nineteen patients were randomized into each of two groups in a placebo-controlled, double-blind clinical trial. The treatment group demonstrated an increase in peak expiratory flow rate from 225 to 297 L/min as compared with 208 to 216 L/min seen in the placebo group. In addition, the number admitted vs discharged was significantly better for the treatment group (7 vs 12) than the placebo group (15 vs 4). Intravenous magnesium sulfate may represent a beneficial adjunct therapy in patients with moderate to severe asthma who show little improvement with beta-agonists. Twit Text FOAVip Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department ????JAMA http://www.kidney.de/pget.php?&tw=1&pmid=2761061 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=2761061 #FOAvip English Wikipedia <ref>{{Cite pmid|2761061}}</ref> Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department #MMPMID2761061 Skobeloff EM; Spivey WH; McNamara RM; Greenspon L JAMA 1989[Sep]; 262 (9): 1210-3 PMID2761061show ga Conventional nebulized beta-agonist therapy has met with disappointing results in an increasing number of moderate to severe asthmatics who may be characterized as "poor responders." Thirty-eight patients suffering from acute exacerbations of moderate to severe asthma were treated in an emergency department with an intravenous infusion of saline placebo or 1.2 g of magnesium sulfate after conventional beta-agonist therapy failed to produce significant improvement in peak expiratory flow rate. Nineteen patients were randomized into each of two groups in a placebo-controlled, double-blind clinical trial. The treatment group demonstrated an increase in peak expiratory flow rate from 225 to 297 L/min as compared with 208 to 216 L/min seen in the placebo group. In addition, the number admitted vs discharged was significantly better for the treatment group (7 vs 12) than the placebo group (15 vs 4). Intravenous magnesium sulfate may represent a beneficial adjunct therapy in patients with moderate to severe asthma who show little improvement with beta-agonists. |*Emergency Service, Hospital[MESH] |Adolescent[MESH] |Adult[MESH] |Aged[MESH] |Asthma/*drug therapy[MESH] |Double-Blind Method[MESH] |Female[MESH] |Humans[MESH] |Infusions, Intravenous[MESH] |Magnesium Sulfate/administration & dosage/*therapeutic use[MESH] |Male[MESH] |Middle Aged[MESH] |Patient Admission[MESH] |Patient Discharge[MESH] |Peak Expiratory Flow Rate[MESH]Intravenous magnesium sulfate for the treatment of acute asthma in the(epmc).pdf DeepDyve Pubget Overpricing